Related Experiment Video
Updated: Jul 11, 2026

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models
Published on: June 30, 2023
Amyloid-beta-induced mitochondrial dysfunction
1Harvey Cushing Institutes of Neuroscience, North Shore-Long Island Jewish Health System, Great Neck, NY 11021, USA.
Abstract:
As an important molecule in the pathogenesis of Alzheimer's disease (AD), amyloid-beta (Abeta) interferes with multiple aspects of mitochondrial function, including energy metabolism failure, production of reactive oxygen species (ROS) and permeability transition pore formation. Recent studies have demonstrated that Abeta progressively accumulates within mitochondrial matrix, providing a direct link to mitochondrial toxicity. Abeta-binding alcohol dehydrogenase (ABAD) is localized to the mitochondrial matrix and binds to mitochondrial Abeta. Interaction of ABAD with Abeta exaggerates Abeta-mediated mitochondrial and neuronal perturbation, leading to impaired synaptic function, and dysfunctional spatial learning/memory. Thus, blockade of ABAD/Abeta interaction may be a potential therapeutic strategy for AD.
Insights
Alzheimer's disease (AD) involves amyloid-beta (Abeta) disrupting mitochondrial function. Blocking the interaction between Abeta and the ABAD enzyme may offer a new therapeutic strategy for AD.
Area of Science:
- Neuroscience
- Mitochondrial Biology
- Alzheimer's Disease Pathogenesis
Background:
- Amyloid-beta (Abeta) is a key factor in Alzheimer's disease (AD) pathogenesis.
- Abeta accumulation within mitochondria directly causes mitochondrial toxicity.
- Mitochondrial dysfunction includes impaired energy metabolism, increased reactive oxygen species (ROS), and altered permeability transition pore formation.
Purpose of the Study:
- To investigate the role of Abeta-binding alcohol dehydrogenase (ABAD) in Abeta-mediated mitochondrial dysfunction in AD.
- To explore the therapeutic potential of blocking the ABAD/Abeta interaction.
Main Methods:
- Localization of ABAD within the mitochondrial matrix.
- Assessment of ABAD's binding to mitochondrial Abeta.
- Evaluation of the impact of ABAD/Abeta interaction on mitochondrial and neuronal function, including synaptic function and spatial learning/memory.
Main Results:
- ABAD is localized to the mitochondrial matrix and binds to mitochondrial Abeta.
- The interaction between ABAD and Abeta exacerbates Abeta-induced mitochondrial and neuronal damage.
- This interaction leads to impaired synaptic function and deficits in spatial learning and memory.
Conclusions:
- The interaction between ABAD and Abeta significantly contributes to neuronal dysfunction in Alzheimer's disease.
- Blocking the ABAD/Abeta interaction presents a promising therapeutic target for AD treatment.
- Targeting this specific molecular interaction could mitigate mitochondrial toxicity and improve cognitive deficits in AD patients.
Related Concept Videos
ATP Synthase: Mechanism
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondria
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...

